Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform Nanotech Investing
Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update Nanotech Investing
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results Nanotech Investing
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update Nanotech Investing
Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss Nanotech Investing
Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI® in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses Nanotech Investing
CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study Nanotech Investing
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026 Nanotech Investing
Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients Nanotech Investing
